Risk Reduction of Non-Hormonal Cancers Following Bariatric Surgery
Document Type
Article
Publication Title
Minerva Surgery
Abstract
Metabolic and bariatric surgery (MBS) is the most effective intervention for weight loss leading to significant resolution of obesity-related medical conditions. Recent literature has demonstrated risk reduction of certain cancer types after MBS. Studies have shown an overall reduction in the risk of hormonal cancer, such as breast and endometrial cancer. However, the association between bariatric surgery and the incidence of various types of non-hormonal cancer such as esophageal, gastric, liver, gallbladder, colorectal, pancreatic and kidney cancer remains contested. The aim of this study was to highlight obesity and its relationship to cancer development as well as bariatric surgery and its role in cancer reduction with focus on non-hormonal cancers.
DOI
10.23736/S2724-5691.23.10104-3
Publication Date
12-2023
Keywords
obesity, bariatric surgery, neoplasms
ISSN
2724-5438
Recommended Citation
Jawhar N, Nakanishi H, Marrero K, Tomey D, Alamy NH, Danaf J, Ghanem OM. Risk Reduction of Non-Hormonal Cancers Following Bariatric Surgery. Minerva Surgery. 2023; 78(6). doi: 10.23736/S2724-5691.23.10104-3.
